Overview

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Status:
Completed
Trial end date:
2019-04-11
Target enrollment:
Participant gender:
Summary
Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibuprofen Topical Gel 5%
Phase:
Phase 2
Details
Lead Sponsor:
Aponia Laboratories, Inc.
Treatments:
Ibuprofen